Epoxy fatty acids reduce corneal opacity and myofibroblast activation after alkali injury

Abstract

Alkali-induced corneal injury causes epithelial damage, corneal opacity, stromal remodeling, and loss of transparency. Epoxy fatty acids (EpFAs), including epoxyeicosatrienoic acids (EETs) and epoxyeicosatetraenoic acids (EEQs), are rapidly hydrolyzed by soluble epoxide hydrolase (sEH). However, their roles in the corneal response to chemical injury remain incompletely defined. We evaluated the effects of EET, EEQ, and the sEH-resistant EET analogs in human corneal fibroblasts, human corneal epithelial cells, and mouse models of NaOH- and ammonia-induced corneal injury. In human corneal fibroblasts, EET and EEQ attenuated TGFβ1-induced α-SMA and collagen III expression, while EEQ also reduced collagen 1A1 expression. In human corneal epithelial cells, EET and EEQ increased the MTT signal after NaOH exposure and increased the percentage of Ki67-positive cells in uninjured cultures. Chemical exposure increased cellular sEH activity in a cell type- and injury-dependent manner. In the mouse NaOH injury model, topical EET or EEQ reduced corneal opacity and stromal α-SMA and fibronectin staining. The sEH-resistant analogs M2 and M4 also reduced TGFβ1-induced α-SMA expression and corneal opacity. Combining EET with TPPU or EC5026 reduced corneal opacity earlier than EET alone. In the ammonia injury model, EET treatment and genetic deletion of sEH were associated with lower corneal opacity and neovascularization scores. Together, these findings show that pharmacological or genetic modulation of the sEH-EpFA pathway modifies the corneal response to alkali injury and is associated with reduced corneal opacity and myofibroblast-associated marker expression. Further studies are required to define the molecular mechanisms linking this pathway to TGFβ signaling and immune responses.

ZRANB1-mediated EZH2 stabilization drives S100B/S100A4 transcriptional activation and corneal neovascularization in alkali burns.
Fangyuan Liu, Ying Xiao, Yeping Huang +3
Biology direct1 Jul 2026Peer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCDOAJ
Longitudinal Changes in Self-Esteem and Evaluation of Patient Satisfaction After Keratopigmentation for Unilateral Corneal Opacity
Rita Hepsi Rani, Thendral Velmurugan
Cureus16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Corneal Stiffening and Hyperosmolar Stress Associate With YAP1/TAZ Activation and Ocular Surface Inflammation in Dry Eye Disease.
Yuanyuan Liu, Huijuan Chen, Kexin Li +8
Translational vision science & technology1 Oct 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
Editor’s Note: ‘Expression of Concern: MGST2hi PMNs mediate NETs and drive pericyte-to-myofibroblast transition in RA-ILD’
American journal of respiratory cell and molecular biology30 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
Visualizing a Lung Opacity Behind Pleural Effusion Using Dynamic Chest Radiography
Hiroki Ichikawa, Takuo Yoshida
Respirology case reports29 Oct 2026Peer-reviewedCC BYFull textMedical imaging & radiologyEurope PMCEurope PMCPMC

Cite

BibTeX RIS

BibTeX

@article{lu2026epoxy,
  title = {{Epoxy fatty acids reduce corneal opacity and myofibroblast activation after alkali injury}},
  author = {Xiaowen Lu and Christophe Morisseau and Zhong Chen and Amy J. Estes and Darryl C. Zeldin and Artiom Gruzdev and Bruce D. Hammock and Mitchell A. Watsky},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = nov,
  doi = {10.3389/fphar.2026.1923374},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1923374},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Epoxy fatty acids reduce corneal opacity and myofibroblast activation after alkali injury
AU  - Xiaowen Lu
AU  - Christophe Morisseau
AU  - Zhong Chen
AU  - Amy J. Estes
AU  - Darryl C. Zeldin
AU  - Artiom Gruzdev
AU  - Bruce D. Hammock
AU  - Mitchell A. Watsky
PY  - 2026
DA  - 2026/11/03
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1923374
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1923374
AB  - Alkali-induced corneal injury causes epithelial damage, corneal opacity, stromal remodeling, and loss of transparency. Epoxy fatty acids (EpFAs), including epoxyeicosatrienoic acids (EETs) and epoxyeicosatetraenoic acids (EEQs), are rapidly hydrolyzed by soluble epoxide hydrolase (sEH). However, their roles in the corneal response to chemical injury remain incompletely defined. We evaluated the effects of EET, EEQ, and the sEH-resistant EET analogs in human corneal fibroblasts, human corneal epithelial cells, and mouse models of NaOH- and ammonia-induced corneal injury. In human corneal fibroblasts, EET and EEQ attenuated TGFβ1-induced α-SMA and collagen III expression, while EEQ also reduced collagen 1A1 expression. In human corneal epithelial cells, EET and EEQ increased the MTT signal after NaOH exposure and increased the percentage of Ki67-positive cells in uninjured cultures. Chemical exposure increased cellular sEH activity in a cell type- and injury-dependent manner. In the mouse NaOH injury model, topical EET or EEQ reduced corneal opacity and stromal α-SMA and fibronectin staining. The sEH-resistant analogs M2 and M4 also reduced TGFβ1-induced α-SMA expression and corneal opacity. Combining EET with TPPU or EC5026 reduced corneal opacity earlier than EET alone. In the ammonia injury model, EET treatment and genetic deletion of sEH were associated with lower corneal opacity and neovascularization scores. Together, these findings show that pharmacological or genetic modulation of the sEH-EpFA pathway modifies the corneal response to alkali injury and is associated with reduced corneal opacity and myofibroblast-associated marker expression. Further studies are required to define the molecular mechanisms linking this pathway to TGFβ signaling and immune responses.
SN  - 1663-9812
ER  -

Abstract

Related

Cite